QT
TSHA icon

Quantbot Technologies’s Taysha Gene Therapies TSHA Stock Holding History

Quantbot Technologies’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-524
Closed -$2.34K – 2255
2026
Q1 		$2.34K Buy
+524
New +$2.44K ﹤0.01% 1604
2023
Q1 		– Sell
-9,729
Closed -$22K – 2079
2022
Q4 		$22K Buy
9,729
+8,900
+1,074% +$18K ﹤0.01% 1433
2022
Q3 		$1K Hold
829
– – ﹤0.01% 1532
2022
Q2 		$3K Sell
829
-2,100
-72% -$8.33K ﹤0.01% 1613
2022
Q1 		$19K Buy
2,929
+2,415
+470% +$18.1K ﹤0.01% 1371
2021
Q4 		$5K Buy
+514
New +$7.75K ﹤0.01% 1379
2020
Q4 		– Sell
-300
Closed -$6K – 1693
2020
Q3 		$6K Buy
+300
New +$7.06K ﹤0.01% 1173

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quantbot Technologies's TSHA Position: Q2 2026 in Review

Quantbot Technologies sold out of Taysha Gene Therapies (TSHA) in Q2 2026, closing a stake of 524 shares — an estimated $2.34K sold.

Quantbot Technologies first reported a position in TSHA in Q3 2020 and held it in 7 quarters. The position peaked at $22K in Q4 2022. 209 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Quantbot Technologies reported no remaining Taysha Gene Therapies position as of Q2 2026 after selling out during the quarter.
  • Quantbot Technologies sold 524 Taysha Gene Therapies shares in Q2 2026, an estimated $2.34K.
  • Quantbot Technologies first reported a position in Taysha Gene Therapies in Q3 2020 and held it in 7 quarters.
  • Quantbot Technologies's Taysha Gene Therapies position peaked at $22K in Q4 2022.
  • 209 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.